Arthritis Advisory Committee

Arthritis Advisory Committee Committee Meeting December 20, 2012, from 8 a.m. to 5 p.m. Agenda: The committee will discuss new drug application (NDA) 22151, rintatolimod injection (proposed trade name AMPLIGEN), submitted by Hemispherx Biopharma, Inc., for the treatment of patients with chronic fatigue syndrome.